Bioterrorism and Infectious Diseases: The Unseen Threat

Pautex Darcy^*
*Correspondence: Pautex Darcy, Department of Virology,, Croatian Institute of Public Health, Croatia, Email:

Introduction

Bioterrorism, the intentional release or dissemination of pathogens to cause harm, represents an emerging and serious threat to global public health. Unlike natural infectious disease outbreaks, bioterrorism is designed to cause widespread panic, disrupt societies and overwhelm healthcare systems with fear and confusion. Pathogens that could be used in bioterrorism include bacteria, viruses and toxins that are capable of causing illness or death, such as anthrax, smallpox, ricin and botulinum toxin. These agents are particularly dangerous because they can spread quickly, causing significant public health crises and straining resources in a short amount of time. The intentional nature of these attacks makes them especially challenging to detect and prevent, as they often occur without warning and may involve sophisticated methods of dissemination, such as aerosol sprays or contamination of food and water supplies [1,2].

Description

The potential for bioterrorism to exploit infectious diseases for malicious purposes has led governments and health organizations to strengthen their preparedness plans. Bioterrorism agents are often selected for their ability to mimic naturally occurring infectious diseases, complicating diagnosis and making it difficult for healthcare providers to distinguish between a natural outbreak and an intentional attack. For example, an anthrax attack could present with symptoms similar to those of a common respiratory infection, such as fever, cough and fatigue, making it difficult to identify in the early stages. Furthermore, the psychological impact of bioterrorism can be just as harmful as the physical effects, as fear and uncertainty can drive widespread panic, disrupt social order and overwhelm healthcare systems, exacerbating the overall impact of the attack. Furthermore, the threat of bioterrorism has led to increased attention on biosecurity measures to prevent the theft or misuse of biological agents. Laboratories, research institutions and facilities that work with dangerous pathogens are now subject to stringent regulations to safeguard against the intentional release of these agents. This includes the use of secure laboratory practices, stringent screening of personnel and close monitoring of the transportation of dangerous biological materials. Governments and international organizations are also working to strengthen regulations surrounding the use of biological agents and to ensure that law enforcement agencies are equipped to prevent bioterrorism-related crimes.

Conclusion

To combat the threat of bioterrorism, significant investments are being made in research and development of countermeasures, including vaccines, treatments and detection technologies. For example, the development of vaccines for high-priority bioterrorism agents like smallpox, anthrax and plague has become a priority for public health agencies. Stockpiling vaccines, medications and medical supplies is a key part of national security efforts, ensuring that sufficient resources are available in the event of an attack. Additionally, advances in diagnostic technologies are helping to improve the speed and accuracy of detecting bioterrorism agents in the field. Rapid diagnostic tests that can identify pathogens within hours, rather than days, are critical in the early detection of bioterrorism, allowing for quicker responses and containment efforts. The growing concern over bioterrorism has also led to the integration of preparedness for biological threats into national and international health security strategies. Countries around the world are developing comprehensive response plans that focus on the rapid detection, containment and treatment of infectious diseases that could be caused by bioterrorism. Public health education and training for healthcare professionals and first responders are vital in ensuring that the healthcare workforce is ready to respond effectively in the event of an attack. Moreover, public awareness campaigns can help manage the public's response to such incidents, providing reassurance and reducing the risk of panic in affected communities.

References

1. Roberts, Thomas C., Robert Langer and Matthew JA Wood. “Advances in oligonucleotide drug delivery.” Nat Rev Drug Discov 19 (2020): 673-694.

Google Scholar, Crossref, Indexed at

2. Liang, Xue-hai, Hong Sun, Wen Shen and Huynh-Hoa Bui, et al. “Antisense oligonucleotides targeting translation inhibitory elements in 5' UTRs can selectively increase protein levels.” Nucleic Acids Res 45 (2017): 9528-9546.

Google Scholar, Crossref, Indexed at